NCT01467609

Brief Summary

Pillcam colon capsule (PCC) endoscopy is a novel strategy tool to inspect colon mucosa. The aim of the present study is to evaluate if PCC endoscopy is able to precisely investigate patients with ulcerative colitis and reach high consistency to conventional colonoscopy.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2009

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2010

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2010

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

October 20, 2011

Completed
19 days until next milestone

First Posted

Study publicly available on registry

November 8, 2011

Completed
Last Updated

November 8, 2011

Status Verified

November 1, 2011

Enrollment Period

1 year

First QC Date

October 20, 2011

Last Update Submit

November 4, 2011

Conditions

Keywords

Pillcam colon capsule endoscopyconventional colonoscopyulcerative colitisendoscopic manifestationcolonoscopy

Outcome Measures

Primary Outcomes (1)

  • Evaluate the accuracy of PCC endoscopy in the survey of ulcerative colitis compared with conventional compared with conventional

    the severity of patients investigated by PCC endoscopy and conventional colonoscopy the extent of evolved lesions extent investigated by PCC endoscopy and conventional colonoscopy the safety of PCC endoscopy course (eg: adverse events during bowel preparation and the course; the completion rate)

Secondary Outcomes (4)

  • the gastrointestinal transit time (transit time from ingestion to excretion), cecum arrival time (transit time from ingestion to the cecum), and colon residence time (transit time from the arrival in the cecum to excretion)

  • clinical data such as age, gender,chief complaint

  • the Mayo score of each case

  • the quality of colonic preparation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

academic hospital endoscopist of digestive department

You may qualify if:

  • Adult patients (aged 18-70)
  • Ulcerative Colitis history
  • Suffering from symptoms such as hematochezia, diarrhea or abdominal pain

You may not qualify if:

  • Patients with a high risk for capsule retention (such as intestinal diverticula, acute abdominal pain without regular defecation indicating intestinal obstruction or a history of abdominal operation or intestinal reconstructed operation),
  • Patients allergic to sodium phosphate or polyethylene glycol (PEG) solution,
  • Patients with a history of Crohn's disease
  • Patients with serious systematic diseases such as congestive heart failure, renal failure or severe liver disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

regular biopsy was taken during conventional colonoscopy according to the activity and position of ulcerative colitis involved.

MeSH Terms

Conditions

Colitis, Ulcerative

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • zhi zheng Ge, MD. Ph.D

    Clinical Professor of Gastroenterology Department, Shanghai Renji Hospital; Director, Head of Digestive Endoscopy Department, Shanghai Renji Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Shanghai Institute of Digestive Disease,Renji Hospital, Shanghai Jiao Tong University School of Medicine

Study Record Dates

First Submitted

October 20, 2011

First Posted

November 8, 2011

Study Start

July 1, 2009

Primary Completion

July 1, 2010

Study Completion

November 1, 2010

Last Updated

November 8, 2011

Record last verified: 2011-11